文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛心脑血管急症

心脏骤停患者接受治疗性低温期间早期唤醒的可行性:治疗性低温与早期唤醒(THAW)试验

Feasibility of early waking cardiac arrest patients whilst receiving therapeutic hypothermia: The therapeutic hypothermia and early waking (THAW) trial.
PubMed 文献 · Resuscitation · 2021-11-27
一句话结论单中心前瞻性观察性预试验显示,选择性的院外心脏骤停昏迷患者在接受TTM33期间于12小时唤醒是安全可行的,可更早进行阳性神经预后评估并缩短ICU停留。

该单中心、前瞻性、非随机、观察性安全性与可行性预试验纳入50例推测心源性、成功复苏的院外心脏骤停(OHCA)患者,均接受TTM33(33°C维持24小时并预防高热72小时)。4例(8%)在最初12小时内死亡并被排除,最终队列46例;基于意向治疗分析,23例(46%)被认为临床稳定、适合早期唤醒;12例基于多种临床因素早期拔管(21.4±8.6小时),拔管时平均核心温度34.2°C。其中5例在入ICU后<48小时转出,平均ICU停留1.8±0.4天;28例(56%)以改良Rankin评分0-2分转出ICU;院内总死亡率为50%(n=25)。作者结论认为,对选择性的OHCA昏迷患者在12小时唤醒是安全可行的,可允许更早的阳性神经预后评估并缩短ICU停留。

要点

  • 单中心前瞻性观察性预试验纳入50例推测心源性OHCA并接受TTM33的患者,4例(8%)在12小时内死亡被排除,最终队列46例。
  • 意向治疗分析中23例(46%)被认为临床稳定、适合早期唤醒;其中12例基于多种临床因素早期拔管,拔管时间21.4±8.6小时,拔管时平均核心温度34.2°C。
  • 12例早期拔管者中5例在入ICU后<48小时转出,平均ICU停留1.8±0.4天;28例(56%)以改良Rankin评分0-2分转出ICU。
  • 院内总死亡率为50%(n=25);作者结论认为对选择性OHCA昏迷患者在12小时唤醒安全可行,可更早进行阳性神经预后评估并缩短ICU停留。

适用人群与场景

  • 成功复苏的院外心脏骤停(OHCA)患者,推测心源性病因,年龄>18岁且恢复自主循环,计划作为心脏骤停后治疗的一部分接受TTM33(33°C维持24小时并预防高热72小时)。

诊断标准与关键阈值

  • 临床稳定性依据生理学与神经学参数及临床评估判定;基于意向治疗分析,46例最终队列中23例(46%)被认为临床稳定、适合早期唤醒。

处置流程与药物剂量

  • 早期唤醒与拔管方案为12小时方案,用于接受TTM33的OHCA患者;实际早期拔管者拔管时间21.4±8.6小时,拔管时继续接受TTM33、平均核心温度34.2°C。
  • TTM33方案为33°C维持24小时,并预防高热72小时。

研究设计与关键结果

  • 单中心、前瞻性、非随机、观察性安全性与可行性预试验,纳入50例连续患者(中位年龄65.5岁,82%男性);4例(8%)在最初12小时内死亡并被排除,最终队列n=46。
  • 意向治疗分析中23例(46%)被认为临床稳定、适合早期唤醒;12例基于多种临床因素早期拔管(21.4±8.6小时),拔管时继续接受TTM33、平均核心温度34.2°C。
  • 12例早期拔管者中5例在入ICU后<48小时转出,平均ICU停留1.8±0.4天;28例(56%)以改良Rankin评分0-2分转出ICU;院内总死亡率为50%(n=25)。

证据类型、等级与局限

  • 证据类型:单中心、前瞻性、非随机、观察性安全性与可行性预试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,对选择性的OHCA昏迷患者在12小时唤醒是安全可行的,可允许更早的阳性神经预后评估并缩短ICU停留。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To determine the safety and feasibility of an early (12 h) waking and extubation protocol for out-of-hospital cardiac arrest (OHCA) patients receiving targeted temperature management (TTM).

METHODS: This was a single-centre, prospective, non-randomised, observational, safety and feasibility pilot study which included successfully resuscitated OHCA patients, of presumed cardiac cause. Inclusion criteria were: OHCA patients aged over 18 years with a return of spontaneous circulation, who were going to receive TTM33 (TTM at 33 °C for 24 h and prevention of hyperthermia for 72 h) as part of their post cardiac arrest care. Clinical stability was measured against physiological and neurological parameters as well as clinical assessment.

RESULTS: 50 consecutive patients were included (median age 65.5 years, 82% male) in the study. Four (8%) patients died within the first twelve hours and were excluded from the final cohort (n = 46). Twenty-three patients (46%) were considered clinically stable and suitable for early waking based on the intention to treat analysis; 12 patients were extubated early based on a variety of clinical factors (21.4 ± 8.6 h) whilst continuing to receive TTM33 with a mean core temperature of 34.2 °C when extubated. Of these, five patients were discharged from the intensive care unit (ICU) <48 h after admission with a mean ICU length of stay 1.8 ± 0.4 days. Twenty-eight patients (56%) were discharged from the ICU with a modified Rankin Score of 0-2. The overall intra-hospital mortality was 50% (n = 25).

CONCLUSIONS: It is safe and feasible to wake selected comatose OHCA patients at 12 h, allowing for earlier positive neuro-prognostication and reduced ICU stay.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Watson N, Karamasis G, Stathogiannis K, et al. Feasibility of early waking cardiac arrest patients whilst receiving therapeutic hypothermia: The therapeutic hypothermia and early waking (THAW) trial. Resuscitation. 2021. PMID: 34848275. doi:10.1016/j.resuscitation.2021.11.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。